Clinical Autonomic Research

, Volume 28, Issue 1, pp 133–134 | Cite as

Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?

Letter to the Editor
  • 42 Downloads

Notes

Compliance with ethical standards

Conflict of interest

None.

Funding

None.

References

  1. 1.
    Madias JE (2017) Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome? Clin Auton Res.  https://doi.org/10.1007/s10286-017-0482-y PubMedGoogle Scholar
  2. 2.
    Y-Hassan S, Tornvall P (2017) Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res.  https://doi.org/10.1007/s10286-017-0465-z Google Scholar
  3. 3.
    Y-Hassan S, Henareh L (2015) Plasma catecholamine levels in patients with takotsubo syndrome: implications for the pathogenesis of the disease. Int J Cardiol 181:35–38CrossRefPubMedGoogle Scholar
  4. 4.
    Christensen TE, Bang LE, Holmvang L, Skovgaard DC, Oturai DB, Soholm H et al (2016) (123)I-MIBG scintigraphy in the subacute state of Takotsubo cardiomyopathy. JACC Cardiovasc Imaging 9:982–990CrossRefPubMedGoogle Scholar
  5. 5.
    Doytchinova A, Hassel JL, Yuan Y, Lin H, Yin D, Adams D et al (2017) Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram. Heart Rhythm 14:25–33CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of CardiologyKarolinska Institutet, Karolinska University HospitalStockholmSweden
  2. 2.Department of Clinical Science and Education SödersjukhusetKarolinska InstitutetStockholmSweden

Personalised recommendations